Rapid detection of point mutations by fluorescence resonance energy transfer and probe melting curves in Candida species

Clinical Chemistry

Volumn 46, Issue 5, 2000, Pages 631-635

  Loeffler, Juergen ^a,b   Hagmeyer, Lars ^a   Hebart, Holger ^a   Henke, Norbert ^a   Schumacher, Ulrike ^a   Einsele, Hermann ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b Abt II   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; DNA; FLUCONAZOLE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDA TROPICALIS; CANDIDIASIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEIC ACID ANALYSIS; POINT MUTATION; POLYMERASE CHAIN REACTION;

CANDIDA; CANDIDA ALBICANS; CANDIDA TROPICALIS;

EID: 0034074230     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/46.5.631     Document Type: Article

References (21)

1. 1. Como JA, Dismukes WE. Oral azole drugs as systemic antifungal therapy. N Engl J Med 1994;330:263-72.
2. 2. Law D, Moore CB, Joseph LA, Keaney MG, Denning D. High incidence of antifungal drug resistance in Candida tropicalis. Int J Antimicrob Ag 1996;7:241-5.
3. 3. Lamb DC, Kelly D, Schunck WH, Shyadehi AZ, Akhtar M, Lowe DJ, et al. The mutation T315A in Candida albicans sterol 14α-demethylase causes reduced enzyme activity and fluconazole resistance through reduced affinity. J Biol Chem 1997;272: 5682-8.
4. 4. Löffler J, Kelly S, Hebart H, Schumacher U, Lass-Floerl C, Einsele H. Molecular analysis of CYP51 from fluconazole-resistant Candida albicans strains. FEMS Microbiol Lett 1997;151:263-8.
5. 5. Kelly S, Lamb D, Loeffler J, Einsele H, Kelly D. The G464S amino acid substitution in Candida albicans sterol 14α-demethylase causes fluconazoie resistance in the clinic through reduced affinity. Biochem Biophys Res Commun 1999;262:174-9.
6. 6. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts. NCCLS Document M-27A. Villanova, PA: NCCLS, 1997.
7. 7. Löffler J, Hebart H, Schumacher U, Reitze H, Einsele H. Comparison of different methods for extraction of DNA of fungal pathogens from cultures and blood. J Clin Microbiol 1997;35:3311-2.
8. 8. Mayers DL. Prevalence and incidence of resistance to zidovudine and other antiretroviral drugs. Am J Med 1997;102:70-5.
9. 9. Visse B, Dumont B, Huraux JM, Fillet AM. Single amino acid change in DNA polymerase is associated with foscarnet resistance in a Varicella zoster virus strain recovered from a patient with AIDS. J Infect Dis 1998;178(Suppl 1):S55-7.
10. 10. Takenouchi T, Sakagawa N, Sugawara M. Detection of gyrA mutations among 335 Pseudomonas aeruginosa strains isolated in Japan and their susceptibilities to fluoroquinolones. Antimicrob Agents Chemother 1999;43:406-9.
11. 11. Barnard R, Futo V, Pecheniuk N, Slattery M, Walsh T. PCR toward the wild-type k-ras and p53 sequences: implications for PCR detection of mutations and cancer diagnosis. Biotechniques 1998;25:684-91.
12. 12. Kyger EM, Krevolin MD, Powell MJ. Detection of the hereditary hemochromatosis gene mutation by real-time fluorescence polymerase chain reaction and peptide nucleic acid clamping. Anal Biochem 1998;260:142-8.
13. 13. Kazazian H, Dowling CE, Waber PG, Huang S, Lo WH. The spectrum of β-thalassemia genes in China and southeast Asia. Blood 1986;68:964-6.
14. 14. Jaksch M, Gerbitz KD, Kilger C. Screening for mitochondrial DNA (mtDNA) point mutations using nonradioactive single strand conformation polymorphism (SSCP) analysis. Clin Biochem 1995;28: 503-9.
15. 15. Fodde R, Losekoot M. Mutation detection by denaturing gradient gel electrophoresis (DGGE). Hum Mutat 1994;3:83-94.
16. 16. Cotton RG. Current methods of mutation detection. Mutat Res 1993;285:125-44.
17. 17. Lay MJ, Wittwer CT. Real-time fluorescence genotyping of factor V Leiden during rapid-cycle PCR. Clin Chem 1997;43:2262-7.
18. 18. Denning D, Baily G, Hood S. Azole resistance in Candida. Eur J Clin Microbiol Infect Dis 1997;16:261-80.
19. 19. Szollosi J, Damjanovich S, Matyus L. Application of fluorescence resonance energy transfer in the clinical laboratory: routine and research. Cytometry 1998;34:159-79.
20. 20. Dianzani I, Camaschella C, Ponzone A, Cotton RG. Dilemmas and progress in mutation detection. Trends Genet 1993;9:403-5.
21. 21. Sanglard D, Ischer F, Monod M, Bille J. Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors. Antimicrob Agents Chemother 1996;40:2300-5.